NO148418C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2`-hydroksy-2-(5-isoksazolylmetyl)-6,7-benzomorfaner - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 2`-hydroksy-2-(5-isoksazolylmetyl)-6,7-benzomorfaner

Info

Publication number
NO148418C
NO148418C NO781310A NO781310A NO148418C NO 148418 C NO148418 C NO 148418C NO 781310 A NO781310 A NO 781310A NO 781310 A NO781310 A NO 781310A NO 148418 C NO148418 C NO 148418C
Authority
NO
Norway
Prior art keywords
isoxsazolylmethyl
benzomorphanes
hydroxy
preparation
therapeutic active
Prior art date
Application number
NO781310A
Other languages
English (en)
Norwegian (no)
Other versions
NO781310L (no
NO148418B (no
Inventor
Herbert Merz
Klaus Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO781310L publication Critical patent/NO781310L/no
Publication of NO148418B publication Critical patent/NO148418B/no
Publication of NO148418C publication Critical patent/NO148418C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO781310A 1977-04-15 1978-04-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2`-hydroksy-2-(5-isoksazolylmetyl)-6,7-benzomorfaner NO148418C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772716687 DE2716687A1 (de) 1977-04-15 1977-04-15 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel

Publications (3)

Publication Number Publication Date
NO781310L NO781310L (no) 1978-10-17
NO148418B NO148418B (no) 1983-06-27
NO148418C true NO148418C (no) 1983-10-05

Family

ID=6006359

Family Applications (1)

Application Number Title Priority Date Filing Date
NO781310A NO148418C (no) 1977-04-15 1978-04-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2`-hydroksy-2-(5-isoksazolylmetyl)-6,7-benzomorfaner

Country Status (25)

Country Link
US (1) US4133888A (it)
JP (1) JPS53130671A (it)
AT (3) AT358192B (it)
AU (1) AU514938B2 (it)
BE (1) BE866013A (it)
CA (1) CA1079726A (it)
CH (1) CH638519A5 (it)
DE (1) DE2716687A1 (it)
DK (1) DK144678C (it)
ES (3) ES468798A1 (it)
FI (1) FI63399C (it)
FR (1) FR2387228A1 (it)
GB (1) GB1575156A (it)
GR (1) GR64819B (it)
IE (1) IE46722B1 (it)
IL (1) IL54509A (it)
IT (1) IT1102595B (it)
LU (1) LU79430A1 (it)
NL (1) NL7803977A (it)
NO (1) NO148418C (it)
NZ (1) NZ186971A (it)
PH (1) PH13854A (it)
PT (1) PT67907B (it)
SE (1) SE430160B (it)
ZA (1) ZA782149B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
NL7907800A (nl) 1979-10-23 1981-04-27 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan, farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werkwijze voor het bereiden van deze verbindingen en de farmaceutische preparaten.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499906A (en) * 1966-05-20 1970-03-10 Merck & Co Inc 5,9-diethyl-2'-hydroxy-2-substituted-6,7-benzomorphans
CS166804B2 (it) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
US3853889A (en) * 1973-07-18 1974-12-10 Bristol Myers Co 3,14-substituted-8-oxamorphinans
DE2411382C3 (de) * 1974-03-09 1979-09-06 C.H. Boehringer Sohn, 6507 Ingelheim 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
DE2437610A1 (de) * 1974-08-05 1976-02-26 Boehringer Sohn Ingelheim Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Also Published As

Publication number Publication date
ES472407A1 (es) 1979-04-01
ATA552079A (de) 1980-06-15
IE46722B1 (en) 1983-09-07
ES468798A1 (es) 1978-12-01
FR2387228A1 (fr) 1978-11-10
CA1079726A (en) 1980-06-17
ES472408A1 (es) 1979-04-01
SE430160B (sv) 1983-10-24
GR64819B (en) 1980-06-03
CH638519A5 (de) 1983-09-30
DK144678C (da) 1982-10-11
PH13854A (en) 1980-10-22
IE780742L (en) 1978-10-15
DE2716687A1 (de) 1978-10-19
FI781025A (fi) 1978-10-16
AU3509878A (en) 1979-10-18
BE866013A (fr) 1978-10-16
ATA551979A (de) 1980-06-15
GB1575156A (en) 1980-09-17
DK163578A (da) 1978-10-16
FR2387228B1 (it) 1981-05-29
US4133888A (en) 1979-01-09
ATA241978A (de) 1980-01-15
DK144678B (da) 1982-05-10
IT1102595B (it) 1985-10-07
NL7803977A (nl) 1978-10-17
AT360666B (de) 1981-01-26
AT360667B (de) 1981-01-26
JPS53130671A (en) 1978-11-14
LU79430A1 (de) 1979-05-25
PT67907B (fr) 1980-06-16
AT358192B (de) 1980-08-25
FI63399C (fi) 1983-06-10
NO781310L (no) 1978-10-17
FI63399B (fi) 1983-02-28
IL54509A (en) 1982-04-30
AU514938B2 (en) 1981-03-05
NO148418B (no) 1983-06-27
NZ186971A (en) 1980-10-24
IT7848887A0 (it) 1978-04-13
ZA782149B (en) 1979-12-27
IL54509A0 (en) 1978-07-31
PT67907A (fr) 1978-05-01
SE7804260L (sv) 1978-10-16

Similar Documents

Publication Publication Date Title
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO148957C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cyklopeptider
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO149065C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO154013C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sesquiterpenderivater.
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO146777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.
NO154088C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner.
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO152172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
NO152839C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.